<p>Representative traces of bladder responses to acidic ATP solution instillation before and after intravesical liposome administration in the control (A), FFRs with NDF (B), and FFRs with DO (C). (D): Protective effects of liposomes on the reduction of ICI during ATP solution stimulation among groups. An asterisk indicates a significant difference between before and after intravesical liposome administration in the same group. (Paired t-test, p<0.05).</p
Bladder drug delivery via catheter instillation is a widely used treatment for recurrence of superfi...
PURPOSE: Adenosine triphosphate (ATP) (Sigma Chemical Co., St. Louis, Missouri) is known to contract...
Liposomes have been used therapeutically and as a local drug delivery system in the blad-der. Howeve...
<p>Representative traces of bladder responses to acidic ATP solution instillation before and after i...
It is now well accepted that ATP released from the bladder urothelium in response to stretch [1] act...
AbstractTo present single institution open-label experience with intravesical liposomes (LPs), a muc...
Objectives. We investigate the effects of intravesical application of adenosine 5'-triphosphate (ATP...
AbstractIntravesical (local) therapy of agents has been effective in delaying or preventing recurren...
<p>Panel A shows original force records of control (black line) and Dicer KO (gray line) bladder str...
Purpose: Adenosine triphosphate (ATP) from the urothelium acts as a sensory neurotransmitter and is ...
The use of liposomes for drug release has demonstrated to be a promising therapeutic platform for bi...
Bladder suburothelial myofibroblasts may modulate both sensory responses from the bladder wall and s...
Liposomes have been used therapeutically and as a local drug delivery system in the bladder. However...
ATP is an important mediator of urgency in women with detrusor overactivity (DO). In order to unders...
Adenosine 5′-triphosphate (ATP) is released in the bladder lumen during filling. Urothelial ATP is p...
Bladder drug delivery via catheter instillation is a widely used treatment for recurrence of superfi...
PURPOSE: Adenosine triphosphate (ATP) (Sigma Chemical Co., St. Louis, Missouri) is known to contract...
Liposomes have been used therapeutically and as a local drug delivery system in the blad-der. Howeve...
<p>Representative traces of bladder responses to acidic ATP solution instillation before and after i...
It is now well accepted that ATP released from the bladder urothelium in response to stretch [1] act...
AbstractTo present single institution open-label experience with intravesical liposomes (LPs), a muc...
Objectives. We investigate the effects of intravesical application of adenosine 5'-triphosphate (ATP...
AbstractIntravesical (local) therapy of agents has been effective in delaying or preventing recurren...
<p>Panel A shows original force records of control (black line) and Dicer KO (gray line) bladder str...
Purpose: Adenosine triphosphate (ATP) from the urothelium acts as a sensory neurotransmitter and is ...
The use of liposomes for drug release has demonstrated to be a promising therapeutic platform for bi...
Bladder suburothelial myofibroblasts may modulate both sensory responses from the bladder wall and s...
Liposomes have been used therapeutically and as a local drug delivery system in the bladder. However...
ATP is an important mediator of urgency in women with detrusor overactivity (DO). In order to unders...
Adenosine 5′-triphosphate (ATP) is released in the bladder lumen during filling. Urothelial ATP is p...
Bladder drug delivery via catheter instillation is a widely used treatment for recurrence of superfi...
PURPOSE: Adenosine triphosphate (ATP) (Sigma Chemical Co., St. Louis, Missouri) is known to contract...
Liposomes have been used therapeutically and as a local drug delivery system in the blad-der. Howeve...